van der Laarse A - Search Results

1

Tumor necrosis factor-alpha plays an important role in restenosis development.

Monraats PS, Pires NM, Schepers A, Agema WR, Boesten LS, de Vries MR, Zwinderman AH, de Maat MP, Doevendans PA, de Winter RJ, Tio RA, Waltenberger J, 't Hart LM, Frants RR, Quax PH, van Vlijmen BJ, Havekes LM, van der Laarse A, van der Wall EE, Jukema JW. Monraats PS, et al. Among authors: van vlijmen bj, van der wall ee, van der laarse a. FASEB J. 2005 Dec;19(14):1998-2004. doi: 10.1096/fj.05-4634com. FASEB J. 2005. PMID: 16319143

2

Raman spectroscopic investigation of atorvastatin, amlodipine, and both on atherosclerotic plaque development in APOE*3 Leiden transgenic mice.

van de Poll SW, Delsing DJ, Jukema JW, Princen HM, Havekes LM, Puppels GJ, van der Laarse A. van de Poll SW, et al. Among authors: van der laarse a. Atherosclerosis. 2002 Sep;164(1):65-71. doi: 10.1016/s0021-9150(02)00055-2. Atherosclerosis. 2002. PMID: 12119194

3

Left ventricular remodeling early after aortic valve replacement: differential effects on diastolic function in aortic valve stenosis and aortic regurgitation.

Lamb HJ, Beyerbacht HP, de Roos A, van der Laarse A, Vliegen HW, Leujes F, Bax JJ, van der Wall EE. Lamb HJ, et al. Among authors: van der wall ee, van der laarse a. J Am Coll Cardiol. 2002 Dec 18;40(12):2182-8. doi: 10.1016/s0735-1097(02)02604-9. J Am Coll Cardiol. 2002. PMID: 12505232 Free article.

4

Effects of amlodipine, atorvastatin and combination of both on advanced atherosclerotic plaque in APOE*3-Leiden transgenic mice.

van de Poll SW, Delsing DJ, Wouter Jukema J, Princen HM, Havekes LM, Puppels GJ, van der Laarse A. van de Poll SW, et al. Among authors: van der laarse a. J Mol Cell Cardiol. 2003 Jan;35(1):109-18. doi: 10.1016/s0022-2828(02)00284-5. J Mol Cell Cardiol. 2003. PMID: 12623305

5

Differential effects of amlodipine and atorvastatin treatment and their combination on atherosclerosis in ApoE*3-Leiden transgenic mice.

Delsing DJ, Jukema JW, van de Wiel MA, Emeis JJ, van der Laarse A, Havekes LM, Princen HM. Delsing DJ, et al. Among authors: van der laarse a, van de wiel ma. J Cardiovasc Pharmacol. 2003 Jul;42(1):63-70. doi: 10.1097/00005344-200307000-00010. J Cardiovasc Pharmacol. 2003. PMID: 12827028

6

Evaluation of ECG criteria for left ventricular hypertrophy before and after aortic valve replacement using magnetic resonance imaging.

Beyerbacht HP, Bax JJ, Lamb HJ, van der Laarse A, Vliegen HW, de Roos A, Zwinderman AH, van der Wall EE. Beyerbacht HP, et al. Among authors: van der wall ee, van der laarse a. J Cardiovasc Magn Reson. 2003 Jul;5(3):465-74. doi: 10.1081/jcmr-120022262. J Cardiovasc Magn Reson. 2003. PMID: 12882077

7

Improvement of serum oxidation by pravastatin might be one of the mechanisms by which endothelial function in dilated coronary artery segments is ameliorated.

Mulder HJ, Schalij MJ, van der Laarse A, Hollaar L, Zwinderman AH, Bruschke AV. Mulder HJ, et al. Among authors: van der laarse a. Atherosclerosis. 2003 Aug;169(2):309-15. doi: 10.1016/s0021-9150(03)00197-7. Atherosclerosis. 2003. PMID: 12921983 Clinical Trial.

8

Current PTCA practice and clinical outcomes in The Netherlands: the real world in the pre-drug-eluting stent era.

Agema WR, Monraats PS, Zwinderman AH, De Winter RJ, Tio RA, Doevendans PA, Waltenberger J, De Maat MP, Frants RR, Atsma DE, Van Der Laarse A, Van Der Wall EE, Jukema JW. Agema WR, et al. Among authors: van der wall ee, van der laarse a. Eur Heart J. 2004 Jul;25(13):1163-70. doi: 10.1016/j.ehj.2004.05.006. Eur Heart J. 2004. PMID: 15231375

9

-455G/A polymorphism and preprocedural plasma levels of fibrinogen show no association with the risk of clinical restenosis in patients with coronary stent placement.

Monraats PS, Rana JS, Zwinderman AH, de Maat MP, Kastelein JP, Agema WR, Doevendans PA, de Winter RJ, Tio RA, Waltenberger J, Frants RR, van der Laarse A, van der Wall EE, Jukema JW. Monraats PS, et al. Among authors: van der wall ee, van der laarse a. Thromb Haemost. 2005 Mar;93(3):564-9. doi: 10.1160/TH04-11-0708. Thromb Haemost. 2005. PMID: 15735811 Clinical Trial.

10

Metabolic syndrome and risk of restenosis in patients undergoing percutaneous coronary intervention.

Rana JS, Monraats PS, Zwinderman AH, de Maat MP, Kastelein JJ, Doevendans PA, de Winter RJ, Tio RA, Frants RR, van der Laarse A, van der Wall EE, Jukema JW; GENDER study. Rana JS, et al. Among authors: van der wall ee, van der laarse a. Diabetes Care. 2005 Apr;28(4):873-7. doi: 10.2337/diacare.28.4.873. Diabetes Care. 2005. PMID: 15793188

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

319 results

Search Page

Filters